Asian News International
The drug, called ZL105, is a compound based on the precious metal iridium. The study has found ZL105 could potentially replace currently used anticancer drugs, which become less effective over time, cause a wide-range of side-effects and damage healthy cells as well as cancerous.
Commenting on the breakthrough,
She said that this makes cancer cells susceptible to minor changes in the cell 'power-house', asserting that their drug pushes cancer cells over the limit causing them to slow and shut down, whilst normal cells can cope with its effects.
Preliminary data indicate that the novel drug may be ten times more effective in treating ovarian, colon, melanoma, renal, and some breast cancers, according to data obtained by the
The researchers now aim to expand the study to cancers that are inherently resistant to existing drugs and to those which have developed resistance after a first round of chemotherapy treatments.
The new study has been published in the journal Angewandte Chemie International Edition. (ANI)
Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.